Related Articles
Treatment sequence in castration-resistant prostate cancer: A retrospective study in the new anti-androgen era
Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer
Effect of dutasteride on castration‑resistant prostate cancer
Clinical predictor of survival following docetaxel‑based chemotherapy
Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience